BSGM - MCAP CO - Biosig Technologies

Biosig Technologies develops cardiac impulse filtering solutions, ensuring surgeons achieve exceptional precision during operations. The current development stage involves adapting these advancements for large-scale partnerships by 2026, while the mass production of equipment has been delegated to external contractors. The price trend on GURU.Markets, where the indicator stands at , confirms the impact of this production model and business transformation strategy.

Assessing the reliability of equity assets begins with an analysis of the business's market value. This indicator is calculated as the product of the share price and the total number of outstanding securities. For Biosig Technologies (BSGM), this metric reflects market confidence in the transition from hardware sales to IT platforms for arrhythmia monitoring. The current market capitalization trend allows for a comparison between the real-time valuation of the business and its ambitions to expand the customer base.